Case Study – Phase 1 Dose Escalation Study With A Bispecific Antibody In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we manage routine and specialty test for a Phase 1 study.
Case Study – Refractory Multiple Myeloma (RRMM)
![Cerba US Expansion Tour VF.00_04_27_19.Still010](https://cerbaresearch.com/app/uploads/2022/07/Cerba-US-Expansion-Tour-VF.00_04_27_19.Still010.jpg)
Reach out to our experts and discover how we can help you advance your clinical trial
Contact Us